Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior.
about
Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variantsProtective and damaging effects of stress mediators: central role of the brainNeuroendocrinal, Neurodevelopmental, and Embryotoxic Effects of Recombinant Tissue Plasminogen Activator Treatment for Pregnant Women with Acute Ischemic StrokeMechanisms of stress in the brainEphBs: an integral link between synaptic function and synaptopathiesNew approaches to antidepressant drug discovery: beyond monoaminesAmygdala protein kinase C epsilon regulates corticotropin-releasing factor and anxiety-like behaviorThe serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptorsAngst and the amygdalaStress-induced glucocorticoid signaling remodels neurovascular coupling through impairment of cerebrovascular inwardly rectifying K+ channel functionCentral role of the brain in stress and adaptation: links to socioeconomic status, health, and disease.Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons.Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling.Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors.Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase.The ever-changing brain: cellular and molecular mechanisms for the effects of stressful experiences.Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex.Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.Tissue plasminogen activator modulates the cellular and behavioral response to cocaine.Inflammation and thrombosis biomarkers and incident frailty in postmenopausal womenPassenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains.Hippocampal regulation of aversive memories.Effects of Ethanol on Brain Extracellular Matrix: Implications for Alcohol Use Disorder.Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy.Neuropsin cleaves EphB2 in the amygdala to control anxiety.BDNF-TrkB signaling through Erk1/2 MAPK phosphorylation mediates the enhancement of fear memory induced by glucocorticoids.Regulation of neuronal plasticity and fear by a dynamic change in PAR1-G protein coupling in the amygdalaTuning synaptic transmission in the hippocampus by stress: the CRH system.Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice.Morphine Withdrawal Increases Brain-Derived Neurotrophic Factor Precursor.Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus.Tissue plasminogen activator in central nervous system physiology and pathology.MARCKSL1 Regulates Spine Formation in the Amygdala and Controls the Hypothalamic-Pituitary-Adrenal Axis and Anxiety-Like Behaviors.Characterization of Tissue Plasminogen Activator Expression and Trafficking in the Adult Murine Brain
P2860
Q21092178-B2B34338-5CC3-4D73-815B-D5D1223A389BQ24635626-29085CF6-62DC-491E-9DCE-50E5FF12AE7DQ26768616-1523FD15-9322-4823-B44B-78581777A97FQ26781233-AD387F68-E268-4E7F-A146-48E62BA8D1D2Q26863347-BF1FB790-4003-4D44-BA0E-6321188A1093Q28293089-1C33B749-C7EE-45AB-9388-FAE5EE6D7164Q28510780-7DBE4319-F833-4394-B728-C52DAFB9E79DQ28771352-0ACD4858-9B2E-4E0C-9CC2-6D9A3EA75489Q30473413-01A78998-BAEE-4277-A9C6-ABFBC0A3334DQ30578856-B3AE41E8-D36F-4700-A5A1-63ADE0F2F6CDQ33829618-9980F217-7189-4075-99FA-61E61B61DA96Q33925737-4DFCAC9C-7362-4F99-AFDE-A46E5408BD55Q34137906-99C07489-E99E-4B0D-9706-42149BB1C365Q34295880-6B80C644-7A66-4F5D-8601-2C094CB62F77Q35033344-4A65E21E-8BC8-4917-871E-95CEC6195B74Q35641897-77831B30-B9B2-4A8B-9E23-03F4117C25B8Q36366738-AAB09881-2946-4029-8431-FDA50308BD00Q36776088-9E583FD0-9D4E-4729-B282-B3434EAFF6A6Q37100946-6C882C79-80BE-4BF4-8E15-5A9387495827Q37369015-A2D8E98A-6538-4DB9-85A6-27B6015A4D02Q37661804-ABDDA3C9-7904-47A8-B2AE-DBF6A6EBDAFFQ37872468-7003EFC6-7213-4B5C-828A-BA78E9567D5FQ38942800-35E2B129-B410-44C9-833E-1614E6606600Q40142332-4E165DC2-E69B-4EB6-802A-6A7E41FF4DB2Q40234087-29BE3FAF-38FF-472E-B025-32AC08967EF8Q41962381-99F56A09-E95E-45D5-8F1F-3BAAA0899D6DQ42116233-A349A7A8-88F8-43F6-A59F-4F026A335EE5Q42513639-E364C442-2EE3-4FE0-85E4-CEC95DDC1A49Q42552734-EEE2216C-4C51-4332-8B88-AE5186C25E43Q42880635-3DDB1335-A279-4162-90A5-ED447C7DA129Q47992008-E03FAE7C-2E47-4F1B-B8CF-FA9EADC4BBC5Q51025843-8745E692-C5EA-497E-A056-B21B49EA05C6Q51992729-049B36BA-B852-407F-BDE4-E2F093E7D4B9Q53425220-D05478FC-CDC5-4D40-A0A3-D7C05B7C8327Q58799360-B5485D05-86BA-4425-8FC7-EA48180FBB7A
P2860
Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Tissue plasminogen activator p ...... ala and anxiety-like behavior.
@en
Tissue plasminogen activator p ...... ala and anxiety-like behavior.
@nl
type
label
Tissue plasminogen activator p ...... ala and anxiety-like behavior.
@en
Tissue plasminogen activator p ...... ala and anxiety-like behavior.
@nl
prefLabel
Tissue plasminogen activator p ...... ala and anxiety-like behavior.
@en
Tissue plasminogen activator p ...... ala and anxiety-like behavior.
@nl
P2093
P2860
P356
P1476
Tissue plasminogen activator p ...... ala and anxiety-like behavior.
@en
P2093
Bruce S McEwen
Constantine Pavlides
Elzbieta Matys
Robert Pawlak
Sidney Strickland
P2860
P304
16345-16350
P356
10.1073/PNAS.0407355101
P407
P50
P577
2004-11-02T00:00:00Z